Skip to content
raclopride

Structure via PubChem · Public domain (PubChem)

EntityQ7279814· pop 7· linked from 515 articles

raclopride

Sign in to save

Also known as (-)-raclopride, S-(-)-raclopride, S-raclopride

Raclopride is a typical antipsychotic. It acts as a selective antagonist on D2 dopamine receptors. It has been used in trials studying Parkinson Disease.

In the Vinony graph

Vinony's link graph records 515 inbound references to raclopride, and connects out to DRD2, medication and nervous system.

It is catalogued under topics including Benzamides, Chemical pages without DrugBank identifier and Chloroarenes.

Vinony links it to 6 Wikipedia language editions.

Chemical data

Formula
C15H20Cl2N2O3
Molecular weight
347.2 g/mol
IUPAC name
3,5-dichloro-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide
SMILES
CCN1CCC[C@H]1CNC(=O)C2=C(C(=CC(=C2OC)Cl)Cl)O
InChIKey
WAOQONBSWFLFPE-VIFPVBQESA-N
XLogP
2.9
Polar surface area
61.8 Ų
H-bond donors
2
H-bond acceptors
4
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule
Indications
obesity

via ChEMBL · EBI

Research

2,950 papers

via PubMed

Wikidata facts

Mass
346.085098
Show 6 more facts
chemical formula
C₁₅H₂₀Cl₂N₂O₃
subject has role
antipsychotics
isomeric SMILES
CCN1CCC[C@H]1CNC(=O)C2=C(C(=CC(=C2OC)Cl)Cl)O
canonical SMILES
CCN1CCCC1CNC(=O)C2=C(C(=CC(=C2OC)Cl)Cl)O
physically interacts with
Dopamine receptor D3
Commons category
Raclopride
Sources (3)

via Wikidata · CC0

~1 min read

Encyclopedic overview

1 sections
Contents
  • References

Raclopride is a typical antipsychotic. It acts as a selective antagonist on D2 dopamine receptors. It has been used in trials studying Parkinson Disease.

Raclopride is selective for D2 and D3 dopamine receptors. {| class="wikitable" style="float:right; margin-left:1em; |+Binding profile !Receptor !Ki |- |D1 |18000 nM |- |D2 |1.8 |- |D3 |3.5 |- |D4 |2400 |} It can be radiolabelled with radioisotopes, e.g. 3H or 11C and used as a tracer for in vitro imaging (autoradiography) as well as in vivo imaging positron emission tomography (PET). Images obtained by cerebral PET scanning (e.g. PET/CT or PET/MRI) allow the non-invasive assessment of the binding capacity of the cerebral D2 dopamine receptor, which can be useful for the diagnosis of movement disorders. In particular, cerebral D2 receptor binding as measured by carbon-11-raclopride (11C-raclopride) has shown to reflect disease severity of Huntington's disease, a genetic disease characterized by selective degeneration of cerebral D2 receptors.

Excerpted from Wikipedia’s “raclopride” article, available under the CC BY-SA 4.0 licence.

Available in 6 languages

via Wikidata sitelinks · CC0

Connections

Categories